Zhihao Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zhihao Li has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Chi Zhang
Department of General Surgery The Sixth Affiliated Hospital, Sun Yat‐sen University Guangzhou Guangdong China
1 shared publicationHaoxian Ke
Department of General Surgery The Sixth Affiliated Hospital, Sun Yat‐sen University Guangzhou Guangdong China
1 shared publicationJiawei Cai
Department of General Surgery The Sixth Affiliated Hospital, Sun Yat‐sen University Guangzhou Guangdong China
1 shared publicationJunfeng Huang
Department of General Surgery The Sixth Affiliated Hospital, Sun Yat‐sen University Guangzhou Guangdong China
1 shared publication- Ming Yuan
Department of General Surgery (Colorectal Surgery) The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong 510655 China
1 shared publication - Ping Lan
Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 21 November 2024
- Published by Wiley in Cancer Medicine
- Vol. 13 (22) , e70267
MTHFD1 Regulates Autophagy to Promote Growth and Metastasis in Colorectal Cancer via the PI3K‐AKT–mTOR Signaling Pathway
Objectives: Methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) is the enzyme with the activities of methylenetetrahydrofolate dehydrogenase, methylenetetrahydrofolate cyclohydrolase, and formyltetrahydrofolate synthetase. Our aim was to elucidate the function of MTHFD1 in colorectal cancer (CRC).Methods: In vitro assessments of the proliferation, invasion, and migration abilities of CRC cells were conducted using Immunohistochemistry, Transwell invasion assays, Western blot (WB), and Cell counting Kit‐8 assays. WB was also utilized to measure autophagy protein levels and PI3K‐AKT‐mTOR signaling pathway expression. Furthermore, the role of MTHFD1 was evaluated in vivo by using subcutaneous xenograft tumor models and lateral tail vein metastasis models of human CRC in nude mice.Results: Overexpression of MTHFD1 promoted the abilities of tumorigenesis and metastasis in CRC in vitro and in vivo and reduced autophagy, attributing to the PI3K‐AKT‐mTOR signaling pathway in CRC cells. In contrast, the down‐regulation of MTHFD1 increased autophagy and suppressed their proliferation, migration, and invasion.Conclusions: MTHFD1 can modulate the PI3K‐AKT‐mTOR signaling pathway to suppress autophagy and stimulate tumorigenesis and metastasis.
- 21 November 2024
- Published by Wiley in Cancer Medicine
- Vol. 13 (22) , e70267
Open AccessMTHFD1 Regulates Autophagy to Promote Growth and Metastasis in Colorectal Cancer via the PI3K‐AKT–mTOR Signaling Pathway
Objectives: Methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) is the enzyme with the activities of methylenetetrahydrofolate dehydrogenase, methylenetetrahydrofolate cyclohydrolase, and formyltetrahydrofolate synthetase. Our aim was to elucidate the function of MTHFD1 in colorectal cancer (CRC).Methods: In vitro assessments of the proliferation, invasion, and migration abilities of CRC cells were conducted using Immunohistochemistry, Transwell invasion assays, Western blot (WB), and Cell counting Kit‐8 assays. WB was also utilized to measure autophagy protein levels and PI3K‐AKT‐mTOR signaling pathway expression. Furthermore, the role of MTHFD1 was evaluated in vivo by using subcutaneous xenograft tumor models and lateral tail vein metastasis models of human CRC in nude mice.Results: Overexpression of MTHFD1 promoted the abilities of tumorigenesis and metastasis in CRC in vitro and in vivo and reduced autophagy, attributing to the PI3K‐AKT‐mTOR signaling pathway in CRC cells. In contrast, the down‐regulation of MTHFD1 increased autophagy and suppressed their proliferation, migration, and invasion.Conclusions: MTHFD1 can modulate the PI3K‐AKT‐mTOR signaling pathway to suppress autophagy and stimulate tumorigenesis and metastasis.